Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Notes underwriting agrmnt
Inv. presentation
Quarterly results
Acq. announced
|
|
Vistagen Therapeutics, Inc. (VTGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/05/2023 |
SC 13G
| Point72 Asset Management, L.P. reports a 5.6% stake in Vistagen Therapeutics, Inc. |
| 08/09/2023 |
SC 13G
| COMMODORE CAPITAL LP reports a 19.7% stake in Vistagen Therapeutics, Inc. |
| 04/14/2022 |
SC 13G
| COMMODORE CAPITAL LP reports a 5.1% stake in VistaGen Therapeutics, Inc. |
| 02/04/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/04/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/22/2021 |
SC 13G
| ACUTA CAPITAL PARTNERS, LLC reports a 8.4% stake in VistaGen Therapeutics, Inc. |
| 02/16/2021 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in VistaGen Therapeutics, Inc. |
| 02/16/2021 |
SC 13G
| ACUTA CAPITAL PARTNERS, LLC reports a 5.4% stake in VistaGen Therapeutics, Inc. |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/18/2020 |
SC 13G
| Rosalind Advisors, Inc. reports a 5.4% stake in VistaGen Therapeutics, Inc. |
| 01/29/2020 |
SC 13G
| Lincoln Park Capital Fund, LLC reports a 9.6% stake in VISTAGEN THERAPEUTICS, INC. |
| 12/20/2017 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in VistaGen Therapeutics, Inc. |
| 12/20/2017 |
SC 13G
| CVI Investments, Inc. reports a 6.1% stake in VistaGen Therapeutics, Inc. |
| 12/14/2017 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 9.2% stake in VistaGen Therapeutics, Inc. |
| 06/22/2016 |
SC 13G
| SPHERA FUNDS MANAGEMENT LTD. reports a 7.6% stake in VistaGen Therapeutics, Inc. |
| 05/19/2016 |
SC 13G
| Empery Asset Management, LP reports a 9.9% stake in VistaGen Therapeutics, Inc. |
| 05/13/2016 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 10% stake in VistaGen Therapeutics, Inc. |
| 02/29/2016 |
SC 13G
| NEXTHERA CAPITAL LP reports a 5.3% stake in VistaGen Therapeutics, Inc. |
| 02/05/2016 |
SC 13G
| Calm Seas Capital LLC reports a 5.9% stake in VISTAGEN THERAPEUTICS, INC. |
| 08/01/2011 |
SC 13G
| Platinum Long Term Growth VII, LLC reports a 12.9% stake in VistaGen Therapeutics, Inc. |
|
|